Cargando…

Indirect Negative Effect of Mutant Ataxin-1 on Short- and Long-Term Synaptic Plasticity in Mouse Models of Spinocerebellar Ataxia Type 1

Spinocerebellar ataxia type 1 (SCA1) is an intractable progressive neurodegenerative disease that leads to a range of movement and motor defects and is eventually lethal. Purkinje cells (PC) are typically the first to show signs of degeneration. SCA1 is caused by an expansion of the polyglutamine tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shuvaev, Anton N., Belozor, Olga S., Mozhei, Oleg I., Shuvaev, Andrey N., Fritsler, Yana V., Khilazheva, Elena D., Mosyagina, Angelina I., Hirai, Hirokazu, Teschemacher, Anja G., Kasparov, Sergey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317252/ https://www.ncbi.nlm.nih.gov/pubmed/35883691 http://dx.doi.org/10.3390/cells11142247

Ejemplares similares

Protective Effect of Memantine on Bergmann Glia and Purkinje Cells Morphology in Optogenetic Model of Neurodegeneration in Mice
por: Shuvaev, Anton N., et al.
Publicado: (2021)

Memantine Disrupts Motor Coordination through Anxiety-like Behavior in CD1 Mice
por: Shuvaev, Anton N., et al.
Publicado: (2022)

Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1
por: Chen, Jiu-Ming, et al.
Publicado: (2022)

Partial Loss of Ataxin-1 Function Contributes to Transcriptional Dysregulation in Spinocerebellar Ataxia Type 1 Pathogenesis
por: Crespo-Barreto, Juan, et al.
Publicado: (2010)

Extracellular S100β Disrupts Bergman Glia Morphology and Synaptic Transmission in Cerebellar Purkinje Cells
por: Belozor, Olga S., et al.
Publicado: (2019)

Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
por: Mozhei, Oleg, et al.
Publicado: (2020)

Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models
por: Matos, Carlos A., et al.
Publicado: (2016)

Blood–Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration
por: Salmina, Alla B., et al.
Publicado: (2021)

Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3
por: Koike, Yuka, et al.
Publicado: (2021)

Ataxin-3, The Spinocerebellar Ataxia Type 3 Neurodegenerative Disorder Protein, Affects Mast Cell Functions
por: Sowa, Anna S., et al.
Publicado: (2022)

Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes
por: Lasagna-Reeves, Cristian A, et al.
Publicado: (2015)

Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
por: Prifti, Matthew V., et al.
Publicado: (2023)

Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies
por: Evers, Melvin M., et al.
Publicado: (2013)

Histone deacetylase-3 interacts with ataxin-7 and is altered in a spinocerebellar ataxia type 7 mouse model
por: Duncan, Carlotta E, et al.
Publicado: (2013)

Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3
por: Johnson, Sean L., et al.
Publicado: (2021)

Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2
por: Afonso, Inês T., et al.
Publicado: (2022)

An understanding of spinocerebellar ataxia
por: Ramachandra, N.B., et al.
Publicado: (2015)

Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3
por: Menzies, Fiona M., et al.
Publicado: (2010)

Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice
por: Nguyen, Huu Phuc, et al.
Publicado: (2013)

TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2
por: Bux, Jessica, et al.
Publicado: (2023)

Spinocerebellar Ataxia 12 Patients have better Quality of Life than Spinocerebellar Ataxia 1 and 2
por: Dabla, Surekha, et al.
Publicado: (2022)

Parkinsonism in Spinocerebellar Ataxia
por: Park, Hyeyoung, et al.
Publicado: (2015)

Spinocerebellar ataxia: an update
por: Sullivan, Roisin, et al.
Publicado: (2018)

Writer's cramp in spinocerebellar ataxia Type 1
por: Khwaja, Geeta Anjum, et al.
Publicado: (2016)

PUMILIO1 Links Epilepsy to Spinocerebellar Ataxia
por: Lyman, Kyle A., et al.
Publicado: (2019)

Therapeutic Strategies for Spinocerebellar Ataxia Type 1
por: Kerkhof, Laurie M. C., et al.
Publicado: (2023)

Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
por: Toonen, Lodewijk J. A., et al.
Publicado: (2018)

Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias
por: Gan, Shi-Rui, et al.
Publicado: (2017)

NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer’s Disease
por: Komleva, Yulia K., et al.
Publicado: (2021)

The Molecular Basis of Spinocerebellar Ataxia Type 7
por: Goswami, Rituparna, et al.
Publicado: (2022)

Fusion of Human Fetal Mesenchymal Stem Cells with “Degenerating” Cerebellar Neurons in Spinocerebellar Ataxia Type 1 Model Mice
por: Huda, Fathul, et al.
Publicado: (2016)

Cell biology of spinocerebellar ataxia
por: Orr, Harry T.
Publicado: (2012)

Cognitive dysfunction in spinocerebellar ataxias
por: Teive, Helio Afonso Ghizoni, et al.
Publicado: (2009)

Neuroradiological Findings in the Spinocerebellar Ataxias
por: Meira, Alex Tiburtino, et al.
Publicado: (2019)

Deletion at ITPR1 Underlies Ataxia in Mice and Spinocerebellar Ataxia 15 in Humans
por: van de Leemput, Joyce, et al.
Publicado: (2007)

Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1
por: Grosch, Anne Sophie, et al.
Publicado: (2020)

Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia
por: Mohamed Ibrahim, Norlinah, et al.
Publicado: (2020)

Quantitative evaluation of upper limb ataxia in spinocerebellar ataxias
por: Kishimoto, Yoshiyuki, et al.
Publicado: (2022)

Expanding the global prevalence of spinocerebellar ataxia type 42
por: Ngo, Kathie, et al.
Publicado: (2018)

Prevalence of RFC1-mediated spinocerebellar ataxia in a North American ataxia cohort
por: Aboud Syriani, Dona, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2rtk653d7uejtcehsso4qfdh28